JointHealth™ express January 21, 2021
This week’s episode of Arthritis At Home features Cheryl Koehn, ACE’s President, and Carrie Barnes, a person living with rheumatoid arthritis and front-line health care professional.
The highly anticipated COVID-19 vaccines (Pfizer BioNTech and Moderna) have arrived in Canada. People with autoimmune arthritis may receive the COVID-19 vaccine. However, they should be aware that no data are currently available on the safety of mRNA COVID-19 vaccines for them.
In this episode of Arthritis At Home, Cheryl Koehn speaks to Carrie Barnes, a person living with rheumatoid arthritis and front-line health care professional, about the COVID-19 vaccine from a patient perspective. They discuss:
Check out these helpful resources to learn more
This week’s episode of Arthritis At Home features Cheryl Koehn, ACE’s President, and Carrie Barnes, a person living with rheumatoid arthritis and front-line health care professional.
The highly anticipated COVID-19 vaccines (Pfizer BioNTech and Moderna) have arrived in Canada. People with autoimmune arthritis may receive the COVID-19 vaccine. However, they should be aware that no data are currently available on the safety of mRNA COVID-19 vaccines for them.
In this episode of Arthritis At Home, Cheryl Koehn speaks to Carrie Barnes, a person living with rheumatoid arthritis and front-line health care professional, about the COVID-19 vaccine from a patient perspective. They discuss:
- Who should patients go to for advice about the COVID-19 vaccine
- Important questions to ask your rheumatologist or family physician
- What factors led Carrie to her decision to go ahead and get vaccinated
- The first dose experience and one week later
- Thoughts about getting the second dose
Check out these helpful resources to learn more
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.